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ABSTRACT
The General Adaptation Syndrome (G.A.S.) was characterized
for chronic forced restraint stress in normal and reserpinized
(1 mg/kg, I.P.) male albino rats.

This was accomplished by

analyzing the interrelationships among brain neurohumoral levei1
(serotonin (5-HT) and norepinephrine (NE) ), serum corticosterone (KS) levels, and various organ weights such as thymus,
testes, pituitaries, and adrenals.
Reserpine was observed to prevent normal rats from adapting to this stress (mortality rate was 50~) possibly via inanition.

It was suggested that the overall non-adaptive effects

produced could ultimately be due to the ability of reserpine
to induce a chemical sympathectomy.

Thus, by depleting the

A.N.S. of accessible NE, an animal would be unable to respond
to a severe change in environment.
Control animals demonstrated both behavioral and neurochemical adaptation in response to this stress.

Initial ex-

citation associated with restraint was related to increased
brain 5-HT levels and decreased brain NE levels.

As the ex-

periment progressed, stress animals became less excitable and
easier to handle which was also associated with the return of
both bra in am in es to norm al levels.
In contrast, reserpinized animals subjected to chronic
restraint stress became progressively rrore excitable and diff1cul t to handle as the experiment proceeded.
iv

This behavior can

best be described by C.N.S, depression associated with extreme
hypersens1t1v1ty to handling.

This progressive change in be•

havior was correlated with the progressive depletion of brain

NE levels, since brain 5·HT remained at relatively normal levels.
The progressive increase in excitation thus appeared to be dependent on NE depletion or release.
Reserpine (1 mg/kg, I.P.) induced a progressive depletion
of brain NE while it did not do so with 5-HT.
prated as indicating that
release,

In contrast

0.5

5~HT

This was inter•

synthesis was equivalent to its

mg/kg, I.P., of reserpine was found

to produce a progressive depletion of 5·HT as well as NE.

On

the other hand, higher doses of reserpine inhibited the serotonin depletion effects produced by the l mg/kg.

In fact, some

animals demonstrated levels above normal following the chron1o
administration of reserpine (2 mg/kg, I.P.).

Therefore, a

poss1ble serotonin•feedbaok mechanism involving the free and
bound oonoentrations of this amine may be 1nd1oated.
Increased brain 5wHT levels

twenty~four

hours after the

th1rtyMseoond dose of reserpine was also suggestive of an ina
creased synthesis rate.

Behavioral exo1tabil1ty was also

found to oharaoter1ze these increased serotonin levels in all

experiments oonduoted,

Norepinephrine, on the other hand,

did not demonstrate any observable changes 1n the rate of syn...
thesis u·nder the influence of ?'eserpine.

v
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I,

INTRODUCTION

The ability of an animal to adapt to both internal
and external changes in environment has been known to be
essential to life since Claude Bernard's discussions on the
"Internal Milieu".

Mod ern research in this field has

amassed evidence which clearly indicates that adaptation to
changes of env i ronment or to a stre ssor i nvo l ve s an in t er play be twee n the central and autonomic nervots systems and
the endocrines, especially the pituitary-adrenal axis.

The

fact that adaptation involves nervous activity has led to
studies of the effects of various drugs acting on the central nervous system on these interrelationships.
Tranquilizers such as reserpine have been especially
studied because their sedative effects indicate an inhibition of the pituitary-adrenal axis.

However, much to the

surprise of previous investigators, reserpine produced
either de pression or stimulation of the pituitary-adrenal
axis in response to acute stressors.

These investigators

studied reserpine in animals subjected to various stressors,
but due to great variation in methodology and experimental
design, divergent views of the effects of reserpine resulted.
To reconcile this state of appar e nt confusion r e cent
investigators have pres e nt e d strong evidence indicating that
reserpine stimulates pituitary- adrenocortical function and
does not inhibit stress acutely.
1

Although this work is well

2

documented, little consideration of the chronic effects of
reserpine in stressed animals has been observed.

A few

isolated experiments on the effects of the chronic administration of reserpine in normal animals have not resulted in
conclusive statements as to specific pituitary-adrenal interactions.

Along with this, little thought has been g iven to

the study of the chronic effects of reserpine on its proposed
central nervous system mediators of tranquilization, norepinephrine (NE) and serotonin (5-HT).
In view of these inadequacies, this investigation was
designed to study of chronic effects of reserpine on the
pituitary-adrenal axis and its proposed C.N.S. mediators of
tranquilization.

It has been the prime purpose of this in-

vestigation to study the interrelationships of the pituitaryadrenal axis and the brain neurohumoral agents NE and 5-HT
with the behavioral sequences observed during chronic reserpine treatment in unstressed and chronically stressed rats.
The significance of this research will reside in its ability
to clarify the mode of action of reserpine in view of attempting to correlate these data with human pharmacology.

II.

REVIEW OF THE LITERATURE

Adaptation
The problem of animal adaptation has interested biologists for some time and has now become of interest to the
pharmacologist since it has been realized that any drug
could be considered a stressor to which an animal should
adapt.

Claude Bernard was first to recognize the neces-

sity to maintain an internal constancy under any environmental change.

Other investigators, including Fredericq,

Pfluger, and Richet (Cannon, 1932) were also quick to realize that in order to carry out such equilibrations under
environmental changes, an animal must possess some regulatory mechanism which could quickly and efficiently meet
these provocative insults.
W. B. Cannon in attempting to solve this problem
suggested that the autonomic nervous system (ANS) is the
initiator of adaptive mechanisms.

He also recognized the

remarkable ability of an animal to maintain a varying internal environment within limitations so as to hold a relative

constancy.

This he termed Homeostasis.

wrote:
"Here then is a striking phenomenon.
Organisms composed of material which
is characterized by the utmost inconstancy and unsteadiness, have somehow
learned the methods of maintaining
constancy and keeping steady in the
presence of cocditions which reasonably might be expected to prove profoundly disturbing."
3

Cannon

4
Cannon proposed that under environmental changes, A.N.S.
stimulation, and espec:t.ally plasma adrenalin, could initiate cellular preparadness, and therefore, permit adaptation.
His main methodological approach was total or partial sympathectomy.

Homeostatic responses were then observed under

normal and stress conditions.

To better appreciate his con-

clusions a passage from his monograph on Homeostasis has
been cited:
"If sympathectomized animals were set free
in the outer world and had to meet its
demands in struggle for food, safety and
warmth, they could be found more or less
defective according to the variable efficiency of their accessory stabilizing
mechanisms. Even in the most favorable
conditions displayed by the sympathectomized dog, however, absense of sympathetic
control of corrective devices is accompanied by an inability to preserve constancy
of the internal environment though the
stress is only moderate."
Not being satisfied with Cannon's theories, Han Selye

(1950) began a long series of experiments demonstrating
that any animal presented with a noxious stressor responds
in a very characteristic pattern elicited by adrenocortical
hyperfunction via anterior pituitary stimulation.

Because

of the impact of his research on modern thinking concerning
homeostatic mechanisms, his major postulates are now outlined:
I.

When an animal is presented with some drastic
change of either its internal or external environment, the pituitary-adrenal axis is stim-

',• .

5
ulated, eliciting an increase in plasma corticosteroids.

These steroids are believed to be

the substances enabling an animal to adapt to
these changes.
II.

With prolonged stress a complete adaptive syndrome can be characterized, known as the General
Adaptation Syndrome (G.A.S.).

III.

The adaptive trigger, the anteriory pituitary, is
essentially controlled by the hypothalamus.

IV.

There is no essential qualitative difference in
the responses to different chronic stresses.

The

differences are basically quantitative.
Cannon's and Selye's theories do not conflict but tend
to expose the true overall picture.

Cannon worked on the

adrenal medulla whereas Selye studied the adrenal cortex.
There is now little dcubt of the central position of the
pituitary-adrenal axis in adaptation, but A.N.S. activity
is assuredly not without importance.

George Sayers (1950)

has compared these relationships in much clearer a fashion.
He states that the adrenocortical hormones play a general
supportive role rather than an initiating role in bodily
processes; whereas the adrenal medulla initiates cellular
and metabolic changes in response to an emergency.

The

adrenal cortex plays a passive role and makes it possible
for various regulatory systems to expend the additional
effort necessary for homeostatic adjustment.

6
The Pituitary-Adrenal

~xis

The relationship between adrenocortical activity and
the pituitary was first demonstrated by Smith (1927).

By

extirpating the pituitary of the rat, he was able to demonstrate a rapid adrenocortical atrophy due to hypophysectomy.
Since this clas s ic investi gation, numerous steroid hormones
have be en i sol ated and identified as eit her s e cretory or
bio synt he ti c precurse r sub s t ances of t he a drena l c ort ex.
The r e l e ase of the se hormones into the general circulation
has bee n found to be dependent upon the elaboration of a
hormone released by t he pituitary, the adrenocorticotrophic
hormone (ACTH) (Vogt, 1960).

It has further been observed

that numerous types of stirrmli (stressors) including chem ical, physiolo g ical and psychological, induce ACTH release,
thus producing a secondary release of the adre nocortical
hormones .
Recently it has also been demonstrated that in addition to a negatfve feedback effect of plasma corticosteroids
on the pituitary, ACTH is also regulated by higher centers
of the C.N.S., particularly the hypothalamus (Harris, 1955).
However, another mediator substance has been postulated as
being responsible for ACTH release during stress situations.
This second mediator has been postulated since there are
no direct nervous connections between the hypothalarrms and
anterior pituitary.

Saffaran (1962) has accurrmlated evi -

dence supporting this view through the extraction and partial
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purification of a hypothalamic factor which will induce
ACTH release from the pituitary in vitro.
The General Adaptive Syndrome
As mentioned previously, Hans Selye has characterized
a syndrome of chronic animal adaptation (1950).

Selye has

conclusively demonstrated the dependence of this syndrome
on the pituitary-adrenocortical function through the
classical methods of endocrinology of extirpation and replacement experiments.

An animal which is presented with

a chronic stressor, will undergo three distinct stages of
change.

An initial stage, or alarm reaction, a secondary

stage of adaptation and finally a stage of exhaustion.
During the first stage, which may last from one to
three days, physiological changes, such as lowered blood
pressure, decreased body temperature, C.N.S. depression,
and antidiuresis, are observed.

During the second stage

the stressor will be compensated for, and these physiological responses will return to normal or even increase.
This second stage will continue until the animal can no
longer adapt to or compensate for the stressor and the animal will pass into the exhaustive stage and eventual death.
There are several organ weight changes which characterize
each peculiar stage of this syndrome.

In general, an increase

in adrenal weight, a decrease of both the thymus and gonadal
weights are indicated during the alarm reaction.

During the

latter stages of the syndrome similar changes will persist or
return to normal.

In terms of hormonal controls, these are

8
associated with increased hormonal activity whereas a decreased organ weight is associated with decreased hormonal
activity.
Throughout th is syndrome several biochemical patterns
also change ind i ca ting spe ci fi c homeostatic adj us tmen ts.
Changes in the biochemistry of the adrenal gland are indicative of ino1•ea.sed adrenal activity.

Increases of adr•eno ..

corticosteroid output and decreases in adrenal cholesterol
and ascorbic acid have been found to be good indexes of ad ...
renocortical hyperactivity.

Within the past four years me-

thods for the direct analysis of plasma and adrenal corticosteroids have also been developed (Guillemin et al (1958).
This development has very greatly enhanced recent endoorino logical and pbartna co logi cal 1 nvestiga t ions concerning the
pituitary-adrenal axis.
Thus, as one can see, adaptation involves many homeostatic mechanisms.

The sequence of events from the initiation

of the adaptive trigger to the final release of a.drenocort1 ...
cal hormones into the general circulation, involves several
chain reactions which are basically controlled through feedback mechanisms.

Therefore, theoretically a drug could either

stimulate or depress any one of these mechanisms and thus alter
the end result.

It should also be a.ppa.rent that although adre ...

11ocort1cal aet1vity may \Je either stimulated 01• inhibited by a
drug, th is does not

1'119

via the C.N,S. alone.

an that th1 s drug p reduces its effects

·...
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PERIPHERAL NERVOUS
SYSTEM

lA
C.N.S.
HYPOTHALAMUS
(LIMBIC SYSTEM) - 1
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ANTERIORf PITUITARY
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,_

\

ACTH

?
•

.II

ADRENAL co RTEX
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ADRENAL
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t

E/NE

Fig. 1 . A theoretical representation of the hypothalamtcoadenohypophyseal-adrenocortical axis and drug action~
~Possible

Sites of Drug Action
(Inhibition or-stimulation)
1.

Drugs can inh ib 1 t any segment of the nervous
segment (A-)

2.

Drugs can act on any of the hormonal secretions
CRF, ACTH, anu KS
They could affect any one of the following
aspects of hormonal secretions:
1. Synthesis
2.

3.

Release
Site of action

Fig. l 1s an attempt at presenting the possibilities of
where a drug could attack the pituitary adrenal axis.

As one

can see there are more than a dozen ways of affecting this
system and still obtair1ing the same end result, either st1mu ...
lat1on or 1nh1bit1on of corticosteroid release.

The most im-

portant point to be made here is the fact that so me 1nvest1ga tors after de term 1ning the effects of a. dn1g on the adrenal

10

corticosteroid will then draw conclusions without examining
drug effects on the intricate sequence of events outlined
above.
The

~of

Action of Reserpine

Reserpine is a crystalline alkaloid obtained from the
plant Rauwolfia serpentina (Schlittler et al, 1954).

This

drug has been known since the time of Arab and Greek physicians and was used in Europe for many years in the treatment
of various anxiety states.

Due to technical difficulties,

reserpine was not isolated nor characterized until 1952 (Mueller
et al), when its sedative and hypotensive effects were also
first exposed.

Although a ggressive animals such as monkeys

could easily be handled after the administration of reserpine,
the animals did not go t o sleep and they could respond to all
external stimuli.

This new type of sedative activity was de-

fined as "tranquilization".
The mode of action of reserpine is one of the most interesting and challenging problems confronting current pharmacology.

Because of its d if.t'u se pharmacological effects, the

mode of action of reserpine has escaped most investigators.
This problem, however, is not peculiar to reserpine, for in
dealing with drugs which affect the psyche, one has the overwhelming problem of attempting to eva.l ua te changes in animal
behavior.
1.

Electrophysiological Mechanisms
The first pharmacological investigations of reserpine

indicated that reserpine inhibited the hypothalamus, initiating

11
sympatholytic or parasympathomimetic effects (Plummer, 1954).
Since these early investigations as to the effects of reserpine on brain electrophysiology, its effects have been observed to be increasingly more complex and diffuse.

Depending upon

the dose used, methods of electrical recording and stimulation,
and on the species of animal used, one observes either
tion or inhibition of many brain areas.
the

effe~ts

facilita~

Domino (1962) summarizes

of reserpine on various electrical systems of the

brain by concluding that reserpine either stimulates or depres ses
most areas of the brain, except for the Limbic System which it
facilitates.
In studying the behavioral pattern of reserpine, Weiskrantz

(1957) observed that reserpine appears to inhibit sensory input
to the brain.

Jacobsen (1959) further studied reserpine under

psychic str ess and found that it produced very nonspecific
effects.

He also stated that the general stupor produced by

reserpine prevented the observation of possible specific effects.
The major problem associated with the study of reserpine
can be summarized best by Bein (1957).

He states:

"Reserpine, which exhibits a complex pattern of
activity, differs from other known substances
having central inhibiting activity, and its
mode of action is of a fundamentally new type."
2.

Neurochemical Me chan isms
Current inte res t in the effects of reserpine on brain

neuro~

humeral agents was initiated by the observation that reserpine
has the ability to reduce normal brain levels of Serotonin
(Pletscher et al, 1956).

(5~HT),

Since reserpine could not be detected

in the brain during maximal sedation, Brodie and Shore 1957
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proceeded with the theory that it exerted its effects by releasing the normally bound 5-HT which would then be free to
inhibit central synapses, thus producing tranquilization (1957).
Holzbauer and Vogt (1956) also found that reserpine depleted norepinephrine (NE) from its normal brain stores and
concluded that reserpine acted as a sympatholytic agent.
Carlsson et al (1 957 ) demonstrated that 3:4 dihydroxyphenylalanine (DOfA), one of the precursors of NE, restored the
normal activity of reserpinized animals, presumably via the
restoration

01

depleted brain NE.

When a reserpinized animal

was administered the precursor of 5-HT, 5-hydroxytryptophan,
no change of activity occurred.

Carlsson (1958) has further

demonstrated that reserpine depletes 3-hydroxytyramine (dopamine), a precursor of NE which is now believed to also possess
a physiological role of its own.

Therefore, Carlsson theorized

that reserpine produces its effects by depriving central synapses
of accessible NE and dopamine.

(This is what Holzhauer and Vogt

essentially proposed.)
Paasonen (1961) aided Carlsson's theory by observing that
raunescine, a rauwolfia alkaloid, also produced sedation similar
to reserpine, which selectively lowered NE to a greater degree
than 5-HT.

He, however, utilized b1oassay procedures for brain

NE and 5-HT determinations as opposed to Brodie's fluorometric
procedures.

Pletscher et al (1959) were also able to demon-

strate differential effects of various benzo qu1nol1z1ne derivatives on these brain amines.

From these studies they showed

that the compound with the greater sedativ e effects, also produced a greater depletion of NE than of 5-HT.
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Although evidence has been presented contradicting Brodie's
original postulates, he has been able to withstand these attacks
with very convincing evidence that reserpine does produce its
effects through 5-HT depletion.

The pres e nt evidence supporti ng

this theory is outlined as follows :

(Brodie et al, 1961, Burns

and Shore, 1961)
1.

Reserpine causes equivalent depletion of both NE
and 5-HT from their normal bound states in the brain.

2.

Brain levels of reserp ine cannot be detected at the
onset of its sedative effects and depletion of both
amines.

3.

5-hydroxytryptophan produces sedative effects similar
to that of reserpine.

4.

Reserpine appears to affect the binding of 5-HT
rather than its synthesis.

5.

Alpha-Methyl-m-Tyrosine depletes the brain of its
NE stores without demonstrating sedative effects.

6.

Cold stress (4° ) four hours prior to the administration of reserpine prevented its sedative effects.
Similarily it also inhibited the depletion of 5-HT
induced by reserpine, but not that of NE.

In a more recent paper, Revizin et al (1961) studying the
effects of alpha-Methyl-m-Tyrosine, tetrabenazine and reserpine,
demonstrated excellent correlation between CNS depression,
evoked Limbic potentials (reserpine usually causes facilitation, Domino, 1962), and lowered 5-HT levels.

They could show

no relationship between NE depletion and evoked potentials.
This last investigation is extremely interesting and important

in view of the fact that it is one of the few attempts at
co r relating CNS behavior with electrical and chemical events.
It shou ld also be pointed out that most of this work involves whole brains with little regard as to what occurs at
the intracellular level.

In an effort to overcome this defi-

ciency Giar m n and Schanberg (1950) and Weil-Malherbe et al
(1961) studied .. en t :o if'uged brain fractions from reserpinized

animals .

Giarman working with 5-HT and Weil-Malherbe working

with NE found that r ese r p i ne inc rease s the FREE/BOUND ratio
of the concent r ations of both amines.
the concentrations of

amin~s

Thi s rati o refers to

of the cytoplasmic fraction to

the concentrations of the amines in the particulate fraction.
The significance of these previous investigations points to
the ability of reserpine to increase the concentrations of NE
and 5-HT in the "Free" form.

It is assume d that the "Free"

form of either amine is that quantity accessable to central
s yna pt 1c s it e s •

Effects of Reserpine

~

the Pituitary-Adrenal

~

Past research on the mechanism of the action of reserpine
has e mphasized the brain neurohumoral agents, 5- HT and NE.
However, within the past two years, renewed interest in the
effects of r e serpine on the adrenal cort ex has been noted.
The endocrine aspects of re fe rpine (0*5 - 1.0 mg/kg) were
first studi ed by Guant e t al (195 \ ) in normal animal s .

From

organ weight data, they concluded that reserpine was a mild
stimulant of the ad renal cortex, while also possessing the
ab ility to depress thymus and gonadal weights of male and fe-
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ma.le albino rats .

Accordingly , reserpine acted as a mild

stressor to which the organism was adapting .
Christian (1956) studied the chronic effects ( three weeks )
of reserpine ( 6 . 67 mg/ml of drinking water) in mice living i n
isolation or crowding.

Reserpine was found to inhibit the ad-

renal growth associated with each stress and was founj to decrease fighting amongst mice subjected to chroni c crowding .
Some animals after two weeks of i solation were suddenly placed
in crowded quarters .

Reserpine was found to have little effect

on the environmental stress in mice induced by the preceeding
change.

It was concluded. that reserp i ne was able to inhibit

the sociological conflicts with no apparent effect on changes
in environment .
In contrast Wells et al (1956 ) found reserpine to be a
potent inhibitor of ACTH release in rats.

Reserpine was admin-

istered ( 2 . 5 mg/kg, I. P.) for five days in order to adapt the
animals to the drug.

On the last day the animals were subjected

to either histamine or e ther stress .

The se workers utilizing

the depletion of adrenal ascorbic acid (AAA) as an index of
adrenocortical hyperfunction, demonstrated that reserpine was
an initial stinmlator of stress, but after five days, inhibited
these super•impos'e d stresses.
Guillemin (1957), while attempting to determine whether any
of the proposed neurohumora.l a.gents (Serotonin, Norepinephrine,
Acetycholine and Histamine) were identical to the Corticotrophic
Releasing Factor (CRF ) , did not agree with previous findings as
to the ability of tranquilizers to inhibit acute stressors.

In
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fact, he found that some of these drugs were themse lves potent
stressors (chlorpromazine and reserpine) although animals in
this investigation were preinjected with the drugs
to the initiation of the stress.

7 days prior

Guillemin's experiment dif-

fered from previous research in that it utilized a psychological stressor, forced restraint stress (holding an animal on
its back for 90 min.).

He observed that while reserpinized

rats did not resist being restrained, the animal still displayed adrenocortical hyperfunction as indicated by the depletion of AAA.
The ability of reserpine to inhibit environmental stressors
was again demonstrated by Mahouz and Ezz (1958).

Utilizing

continuous ether anesthesia withe..xmnguination, heat stress,
and cold stress, they found that reserpine inhibited the usual
depletion of AAA associated with these stressors.

Since re-

serpine was not able to inhibit the usual depletion of AAA by
various doses of ACTH, and reserpine did inhibit the above
mentioned stressors, these workers concluded that reserpine
inhibited the

pituitar~-adrenal

axis by inhibiting some central

regulatory mechanism, possibly the

hypothalrunµ~.

A novel theory of reserpine inhibition of ACTH release
was reported by Kitay et al (1959).

They contend that reser-

pine could cause depletion of ACTH, such that a stress following its administration would be unable to induce ACTH release,
because of exhausted ACTH stores.

Thus, a drug could appear

to inhibit the pituitary, but in essence, be actually stimulating it.

This research has been extremely controversial, but
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might help explain previous divergent results concerning drug
effects on the pituitary-adrenal axis.
Saffaran and Vogt, (1960), found that

2.5

mg/kg of reser•

pine (I.P.) caused ACTH release equivalent to that produced
by the reserpine vehicle . used in this experiment (the identical vehicle used in this investigation).

These workers studied

the effects of reserpine on the pituitary directly by estimating the ACTH content of the pituitary, by in vitro methods.
They further demonstrated that the depletion of ACTH by reserpine lasted only five days,

Thus, they also concluded that at

best reserpine affected the pituitary-adrenal axis as a nonspecific stressor,
Recently Montanari and Stockham (1962) 1 have clarified
to some degree previous conflicting reports.

They have demon-

strated that a single 2,5 mg/kg dose of reserpine produces an
increase

in the plasma oortioosterone levels.

After the adm1n-

1stra tion of this dose for four days, ether still produced
adrenocort1oal hyperfUnotion (an increase of the plasma cort1•
costerone levels ) ,

This finding, therefore, appears to contra-

dict the predictions of Kitay et al (1959) and Maiokel et al (1961 ) ,
In a series of interesting papers, Maiokel, Westermann and
Brodie (1962) have demonstrated excellent correlation between
ACTH release and decreased brain serotonin levels.

Maickel

et al (1961) showed that reserpine was able to stimulate the
pituitary-adrenal axis as evidenced by increased plasma
oosterone levels.

oort1~

By studying these changes 1t was concluded

that reserpine (5 mg/kg, I.V.)

produced a persistent
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stimulation of ACTH for at least 20 hours.

An equivalent

effect was also observed during the exposure of rats to 20
hrs ~ of a cold stressor

(4°c.).

A similar relationship be-

tween cold stress and reserpine was also demonstrated by their
ability to deplete the pituitary of its normal stores of ACTH
by at least 75%.

Westermann et al (1962) in their most recent

publication again demonstrated the ability of reserpine to induce ACTH release, but with selective NE and 5-HT depleters
(alpha-MMT and various benzoquinolizine derivatives) have pre sented excellent evidence indicating the dependence of ACTH
. release on brain serotonin.

With the combined efforts of these

workers and others {Revizin et al, 1961) they have presented a
good case indicating the relation between Limbic stimulation
via reserpine and ACTH release.
The Present Investigation
In reviewing the research concerning the mode of action
of reserpine, the lack of correlation between different investigations at first may not be obvious unless one critically reads
the papers cited here.

The major difficulty in this research

has been the inability of different investigators to agree on
approaches and methods in which to study the mode of action of
reserpine.

This is especially true of investigations involving

· reserpine and its effects on· the pituitary-adrenal axis.
It has been found very frustrating to observe different
workers criticizing each other while at the same time they are
studying reserpine in different systems .

A good example of

this is Montanari's (1962) statement that reserpine does not
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exhaust the pituitary of its ACTH stores as a means of pituitary inhibition of further stresses as proposed by Maicke].
Maickel studied ACTH directly in the pituitary, whereas
Montanari based his conclusions on adrenal and plasma corticosterone levels.

He apparently overlooked the possibili ty

that reserpine may also be acting directly on the adrenal
cortex.

A second example of this criticism is the fact that

different workers utilize different indexes for determining
pituitary-adrenal function when criticizing each other as to
whether reserpine stimulates or inhibits the pituitary adrenal
axis, (adrenal ascorbic acid and plasma corticosterone).

This

point is of even more importance since Montanari and Stockham
(1962) have shown that AAA and plasma cortlcosterone do not
always parellel each other in response to pituitary-adrenal
stimulation.
A second criticism of previous research in this area is
the apparent disregard of basic pharmacological principles in
studying the mechanism of action of reserpine.

Throughout

pharmacology's short history, much has been learned by studying the effects of chronic doses of drugs, especially in
relation to the modes of action and side effects of drugs.
In spite of this, present investigators refuse to study the
effects of drugs chronically in attempting to fortify their
own theories as to mechanisms of action.

In relation to

this, few investigators have taken the time out to study
the chronic effects of reserpine on brain neurohumeral levels
or the pituitary-adrenal axis.
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It would seem logical to conclude that if reserpine
acts by depleting normal brain 5-HT levels after one dose,
it should also do so after thirty-two or even one hundred
doses.

Reserpine stimulation or inhibition of the pituitary-

adrenal axis should also fall under the same analogy.

If

the thirty-second or one hundredth dose does not induce similar
effects as the first dose, then either the drug does not act
via this mechanism or the mechanism is being obscured by a
s e condary cause.

Very few workers have utilized such an ap-

proach and because of this dismaying fact, the present investigation was initiated.
In view of these statements the following hypothesis
concerning the relationship between chronic stress and reserpine sedation will be presented:
H;ypothesis I
If reserpine is either a specific stimulant or depressent
of pituitary-adrenocortical hyperf'unction in response to stress
then these effects should be maintained throughout the duration of the present experiment.
Hypothesis II
If reserpine produces its sedative effects by releasing
either brain NE or 5-HT, then these effects should persist
throughout the duration of the experiment.
H;ypothesis III
If either of the above statements cannot be shown to
be true, then either reserpine does not act by these mechanisms, or a secondary effect is obscuring them.
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Since the first pages of this dessertation constant reference has been made to animal adaptation to environmental
changes and the possible effects of drugs on various segments
of these homeostatic mechanisms (Fig. 1).

The above hypotheses

make 11 ttle mention of too se ideas but were certainly instrurrBn t al in their formulation.
Unfortunately many drugs which affect the C.N.S. are
usually only studied in normal animals.

This may appear irre-

levant to this investigation, but when one considers that drugs
are usually used in the treatment of diseased states rather
than normal activity, this fact does have importance.

It would

also be important to know how drugs affect animal responses to
environmental stressors, since many drugs are used for long
periods of ti me in human therapeutics.

This is especially true

for reserpine.
Thus, aside from attempting to learn rrore about the mode
of action of reserpine, the importance of studying drug effects
in chronically stressed animals from the view point of human
pharmacology was a loo emphasized.

III EXPERIMENTAL
General
Male albino rats (150-220 g) of the Sprague Dawley
strain were used throughout this investigation.
was dissolved in a solution consisting of:
glycol, 1% benzyl alcohol and

0.25%

Reserpine

1

10% polyethylene

citric acid.

The following general procedures were conducted throughout this investigation except where otherwise stated:
1.

Solutions of reserpine were prepared such that each
dose was equivalent to 1 ml/kg.

2.

All animals serving as controls received 1 ml/kg,
T.P., of the reserpine vehicle.

3.

In ea.ch individual experiment a.11 anirr,a.ls were administered either reserpine or its vehicle at 8:00
A .M.

4.

Except where otherwise stated, all animals were
sacrificed by decapitation 8 hours following the
administration of reserpine or its vehicle.

5.

All animals used in chronic experiments initially
weighed between 145 and 160 g.

All other animals

used weighed vetween 190 and 220 g.
In order to determine the degree of sedation produced by
reserpine three characteristic symptoms were utilized.
were:

These

sedation, bleopharospasm or ptosls (eye closure) and

1 Kindly supplied by Dr. R. Gaunt, Ciba Pharmaceuticals, Inc.,
Summit, New Jersey

23
diarrhea (Montanari and Stockham, 1962).

In normal animals

this syndrome was always observable indicating the inability
of

animals to develop tolerance to reserpine.

Ptosis, how-

ever, was found to be of little quantitative value due to
daily sutjective interpretations.
Design of

E~periments

Due to the complex nature of this investigation, it was
found necessary to perform three
1.

m~jor

interrelated experiments.

Single and Repeated D)se Recovery Experiments with
Reserpine

This experiment was designed to determine the recovery
of serum corticosterone (KS) and brain serotonin (5-HT) and
norepinephrine (NE) following one and thirty-two doses of reserpine (1 mg/kg, I.P.) respectively.

Thirty-two animals

receiving a single dose of reserpine were sacrificed at either

4, 8, 12, or 24 hours following its administration.

Twenty-

four animals serving as controls were also sacrificed at equivalent times.
Animals were preinjected with the reserpine vehicle (1 ml/kg,
I.P.) every other day for 14 days to permit adaptation to both
vehicle and injection procedure.

Experiments were conducted on

the 15th day.
Similar experiments were conducted following 32 doses of
reserpine.

Twenty-eight animals receiving reserpine (1 mg/kg,

I.P.) daily were sacrificed at either 8, 24, 80, or 154 hours
following the last dose of reserpine.

An equal number of ani-

mals serving as controls were also sacrificed.
ment animals were allowed food ad libitum.

In this experi-
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2.

Effects of Chronic Restraint Stress in Normal and
Reserp1nized Male Albino Rats

This experiment was designed to test the previous hypotheses made.

It was hoped that this experiment would ultima-

tely determine whether reserpine possessed any specific effects
on the pituitary-adrenal axis.
One hundred and eighty animals initially weighing 145-160 g
were used in the experiment.

Animals in each experiment were

divided into four experimental groups.
1 - CONTROL (These animals received (1 ml/kg, I.P.) the

reserpine vehicle daily)
2 - STRESS

(Control animals + a daily forced restraint
stress)

3 - CONTROL + RESERPINE (These animals received 1 mg/kg,
I.P. of reserpine daily)

4-

STRESS + RESERPINE (These animals received 1 mg/kg,
I.P. of reserpine daily + restraint stress
daily)

Individual experiments of 1, 6, 12, 18, and 32 days were
conducted.

Stressed animals were subjected daily to a forced

restraint stressor for a period of three hours by tying these
animals on their backs to specially constructed boards (Renaud,

1959).

Stress was initiated

5

hours after reserpine or its

vehicle was administered to respective experimental groups.
Animals were sacrificed immediately following release from restraint at the termination of the above mentioned experiments.
The animals of both stress groups were housed singly in
standard metabolism cages constructed to isolate them from
light stimuli while not under restraint.

Control animals (un-

stressed) were housed in similar metabolism cages, two animals

per cage; these animals were not isolated fr om light stimuli.
Urine volume, water and food intake were determined daily
for all experimental groups in each experiment.
was allowed 18 g of purina rat chow daily.

Each animal

This quantity of

food was based on the average food intake for rats receiving
chronic reserpine treatment (1 mg/kg, I.P.).
Effects Qf Single

3.

pine in Normal

~Repeated

Graded Doses £.!.Reser-

~ ~lbino ~

Thia experiment was a second attempt at determining whether
reserpine possesses any specific effects on the pituitary-adrenal axis.

It was also utilized to clarify the int errelation-

ships between reserpine sedation and brain 5-HT and NE levels.
Single graded doses of reserpine,

0.5,

1.0,

2.5,

and

5.0

mg/kg, I.P., were administered to male albino rats (8 animals/
dose).

Eight hours following administration all animals were

sacrificed.

These animals were also pre1njected with the re-

serpine vehicle as 1n the first experiment (every other day
for

14

days).

A repeated graded dose experiment was also conducted using

64 male rats.

These animals were divided into four groups.

Three groups received different doses of reserpine (0.5, 1.0,
and 2.0 mg/kg, I.P.); the last group serving as control.

All

animals were sacrificed 8 hours after the 32nd dose of reserpine.

Dose s of reserpine and its vebicle were administered

each day at 8:00 A.M.
In an attempt to separate rats which would be sensitive or
resistant '00 reserpine, a special feeding and housing schedul 0
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was utilized.

This schedule was based on the premise that

sensitive rats would eat less and thus, present a decreased
rate of growth.

This is a logical statement since the degree

of reserpine-induced inan i tion is dependent on its dose (Gaunt
et al, 1954).

In relation to sensitive and normal reserpinized

rats, resistant rats would be expected to eat more and present
a greater rate of growth.
The schedule used is as follows:
1.

Animals were allowed 18 g of food/animal for 10 days
and were housed 20 animals/cage.

2.

Animals were then subdivided by weight groups and
placed in cages in groups of 10 animals/cage.

Food

was allowed ad libitum.

3.

After 20 days of the experiment animals were again
subdivided into three weight groups of 6-8 animals
per group.

Sacrifice, Removal and Preservation£! Tissue
Sacrifice was accomplished by decapitation with a manua l
guillotine 1 •

Blood was collected in 12 ml centrifu ge tubes

and allowed to stand for 8 to 16 hrs. in a cold room (12°c).
Blood samples were then centrifuged at 2,000 R.P.M., serum re moved by decantation and stored at -10°c until assay .
Brains were removed within two minutes after sacrific e
and frozen immediately in test tubes immersed in a fr ee zing
mixture of solid carbon dioxide and trichlorethylene.

The

brains were later removed from the tubes and preserve d in t1n(Al)
foil at -10° until assay.
1 Harvard Instrument Co.
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Organ Weight Data
Following the removal of brains, rat carcasses were
placed in a cold room (12 0 ) and were autopsied no later than
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hrs after sacrifice.

At autopsy, the adrenals, pituitaries,

thymus and testes of each animal were removed, freed of fatty
tissue, blotted and weighed to the nearest 0.1 mg on a micro
tissue balance.
After weighing, the adrenal glands were dried to a constant weight in an oven at l05°c.

In some instances pituitar-

ies were air dried in a desiccator and weighed (due to the small
weights involved mean weights were determined by pooling groups
of pituitaries).
Chemical Assays
1.

Serum Corticosterone (KS)

In rats, the major adrenal corticosteroid has been determined to be corticosterone (Zenker and Bernstein, 1958).

KS

levels were determined according to the speotrofluorometr1c
method of Guillemin et al (1959) 1n which corticosterone developes a fluorescent product in

84%

H2S04. Fluorescence was read
on an Aminco-Bowman Spectrofluorometer 1 at an activating wave
length of 470 mu and a fluorescent wave length of 510 mu (photomultiplier 'tube

= IP21).

Standard curves (external standards)
were prepared by running known amounts of' corticosterone 2 (0.2-1.0

ug/ml) through the assay procedure.

98±5% (±

S.D., N=6).

Recoveries from serum were

Values were reported as ug/100 ml. of serum9

~~~~~- -~~~~~~~~~~~~~~~~~·

1

American Instrument Co, In all experiments ut111zing this instrument assays were performed in quartz cuvettes ut111zing an
Xenon light source with a No. 5 slit arrangement.

2 Kindly supplied by Dr. G. C. Strayer, Sobering Co., Bloomfield,
N• J •
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2.

Brain Serotonin (5-HT)

~

Norepinephrine

(~)

Brains were homogenized with O.lN HCl in a Teflon Homogenizer and a 3-6 ml aliquot of the homogenate (300-400 mg
of brain/ml) was taken for assay.

Assays were usually per-

formed on pooled samples (2-5 brains/pool) except where indicated.

Both amines were extracted with an NE butanol extrac-

tion procedure which has also been used to extract 5-HT (Mead
and

~inger,

1961).

Serotonin was assayed by its natural fluo-

rescence at an activating wave length oj 292 mu and a fluorescent wave length of 342 mu (photomultiplier tube = IP28) in
an Aminco-Bowman Spectrofluorometer.

Brain NE was assayed by

the development of fluorescence with potassium ferricyanide
(Maynert and Klingman, 1962).

Its wave lengths for activation

and fluorescence were respectively 475 mu and 520 mu.

It was

also measured in an Aminco-Bowman Spectrofluorometer (photomultiplier tube= IP21).
Standard curves (external standards) were prepared by
running known concentrations of both NE 1 and 5-HT1 (0.5-5.0
ug/ml) through the assay procedure.

Recoveries from grain

homogenates were 95±10% (± S.D., N=6) and 76!8% (± S.D., N=l2)
respectively for NE and 5-HT.

Values were reported as uug of

free base/g of brain tissue.

Duplicates for NE determinations

were run with each assay.

Duplication between homogenates for

each amine was of the order of 97% (S.D.=~3.3%).
Klingman, (1962) reported a

s.n.

Maynert and

of ±2.7%.

1 Both amines were obtained from Nutritional Biochemical Corp.,
Cleveland, Ohio. NE was used as the free base, whereas 5-HT
was used as the Creatinine sulfate.
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Control

~

Before the results obtained from these experiments is
presented, the validity and variability of the control data
should be discussed (TABLES I=XV).

During the chronic rest1aint

experiment, controls were separated from experimental animals
by one closed door.

Although no animals were restrained in the

presence of control animals, they were released from restraint
in their presence.

Aside from the presence of other species in

the animal room, several other persons conducting research were
also present at various times .

All of these factors, therefore,

appeared to exert an influence as observed from the presentation
of control data.

Therefore, all anirrals (normal and reserpini-

zed) were subjected to an inconsistent type of stress.

If each

control value is compared against the mean value, this variable
is demonstratable.

Furthermore, the control animals present dur- ·

ing this experiment also exhibited a slight G. A.S. of their cwn.
The recovery experiments following 1 mg/kg reserpine also
demonstrate the daily variability of control data (TABLES I & II).
The results presented and discussed in this investigation
have all been interpreted in light of this great variability,
and were compared in some manner with a control value at the
appropriate day or time of day.
Although the data presented demonstrate · great variation
(control and experimental) as demonstrated by the high standard
deviations, the data presented are considered accurate and valid,
due to the consistency of the values.
It should further be added that the organ weight relationships expressed in the following tables and figures, were not
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expressed as relative weights {'weight/100 g of animal), but
as absolute weights.

This preference was utilized because of

the large variation in the growth rates of different groups
of animals (TABLE III).
Finally, all values reported were analyzed statistica lly
utilizing the student "t" test (Burn, 19)2).

The level of

significance used throughout this research was at the 0.05
level .

IV.
Single

RESULTS AND DISCUSSION

~Repeated

Dose Recovery Experiments

with Reserpine
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TABLE t
'1'BB QOCVIRY OF PITUITARY-ADRENAL P'ONCTION AND BRAIN

NOREPmEPHRINE A.ND SEROTONIN LEVELS PULW'WING A
SINGLE mSE OF RESERPINE IN MALE ALBINO RA'l'Sa

HOUR
011'

DAl .

12too0

A.M.

8:00
P.M.

1

SERUMb

BRAIN

OOttTICOSTERONE
~, (XS)

SEROTONIN

(.5-RT)

(NE)

"ug/100 ml
:_ +
I
39•0;15.0
(8)
10,.6-3 .0(8)

uug/g

uug/g

17~. 0;10. 0 ( 8)
21-'. 7-8.0(6)

8tOO

'IJ),lC26
$86:!'87

" 2862'179

~;g:~i

123i'42
2sot79

3s1;2a
466-64

llzi'l.2

481%61

343i'16o

4113!'33

21s;112·

s29t90

A ..M..

a - The dose

I'

BRADl
NOREPIREPBRllfB

~t

623•34

reserpine was l mg/kg, I.P.

b - The values 1n this column represent the number ot animals
1tudied. ·. For brain assays pools ot two bl'a1na eaoh were
used.
·
s

~~ S1gn1t1oai:it tro~

S.D.

C• ~ A~l

·

·-:.

:

control values.

All values are means t

,;:

.

an1ma1-• were . a&d.ni•tered . e1tber ditug or Yebhla a~
hour (ho!'lz.o ntal) are
oontrol values.
~tOO A.M. · The lower values at each
,.,.
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TIME AFTER RESERPINE ( HOt1RS)

Fig. 2. The re la. t1onsh1p be tween pi tu 1 tary·-adr enooort t ca.1 rie sponse s and brain neurohumoral changes following a single dose
of reserp 1ne ( l mg/kg, I.P.)
Levels of serum oorticosterone ( = ·~,j ), bra.in serotonin ( _A--6) and bra.in noreptnephrine (li---- 1!) were given. Ea.ch
point represents tbe mean of either 6 to 8 animals or 3 to 4
brain pools (2 brains/pool) ·
(A) This curve represents the actual serum cort1costerone changes following a single dose of reserpine.
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TABLE II
THE RECOVERY OF PITUITARY-ADRENAL PT1NCTION AND BRAIN

NOREPINEPHRINE AND SEROTONIN LEVELS FOLLOWINGa
REPE~TED DAILY DOSES OF RESERPINE (32 Days)

TIMEb

SERUMc
CORTICOSTERONE
(KS)

BRAIN
SEROTONIN
( 5-HT)

BRAIN
N OREP INEPHRINE

(NE)

hr

uug/100 ml

uug/g

uug/g

8

27.9~10.5(10)
25.0-12.0(8)

422!"83
605±77

165d
498±191

15.8-6.0(6)

973±546 5
534!"29

163:t'23s
623t29

16.o:t8.0(8)
27.3'±'9.0(6)

620±200
56JI69

106:t-23S
645t"l68

47.o:t18.5(4)
34.ot-17.0(8)

495:!'92
697:!'123

399±92

9.5~4.0(6)

24

80

152

2~. ?e

a - The dose of reserpine was 1 mg/kg, I.P.
b - Time refers to time after the last dose of reserpine.
c - The values in this column represent the number of animals studied. For brain assays pools of two brains each
were used.
d - Two of 3 brains assayed exhibited no NE.
e - Represents a pooled value (4 brains).
s - Signi.ficant from control values.

± S.D.

All values are means
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DISCUSSION
Reserpine (1 mg/kg, I.P.) was observed to produce acute
pituitary-adrenocortical activation as indicated by the increase in serum KS levels four hours following its administration (TABLE I, Fig. 2).

This effect was not observed to

be continuous with res erpine-induce sedation since at the
time of maximal sedation, 8-12 hrs following its administration, serum KS levels were either decree.sing or below normal
levels.

A similar lack of correlation was also observed with

brain NE and 5-HT depletion.

Therefore, pituitary-adrenocor-

tical activation did not appear to be dependent upon brain NE
or 5-HT levels nor upon reserpine-induced sedation.

These re -

sults are in direct conflict with the work of Westermann et
al (1962 ) who have shown a relationship between reserpinedepletion of brain 5-HT and increased serum KS levels.

Since

these investigators did not preinject their animals prior to
drug administration, they may not have observed the desired
specific effect necessary for such a conclusion.
Reserpine also appeared to inhibit the diurnal variation
of serum KS levels at 4:00 P.M. (TABLE I).

Whether this ef-

fect was induced by sedation or via pituitary exhaustion is
not clear.

The significance of this finding, however, is evi-

dent after reading the papers of Westermann et al (1962) and
Montanari and Stockham (1962).

These workers have neglected

to analyze their own data in light of daily serum KS variation,
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or have made no mention of its presence.

Therefore, it is

difficult to imagine how these workers could conclude that
reserpine-induced pituitary-adrenocortical activation was
continuous with its sedative effects.

As one can see, reser-

pine appears to possess a stimulating effect when considering
actual KS levels (TABLE I, Fig. 2A)), whereas when compared to
control levels, inhibition is evident (at 4:00 P.M.).
Recpvery from chronic reserpine administration
I

1 mg/kg,

I.P.), however, appears to produce an inhibition of the pituitary-adrenocortical axis variation
istration (TABLE II, Fig. 3).

24 hrs following its admin-

The decreased serum KS values

80 hours following the last dose of reserpine suggests pit1tuitary-adrenocortical inhibition by reserpine.

This fact is

further verified by the apparent adrenocortical compensation
demonstrated by increased serum KS levels 152 hours following
the 32nd dose of reserpine.

Since serum levels were slightly

&bove normal 8 hrs following reserpine administration on the
32nd day, subsequent pitu1tary-adrenocortical inhibition may
have resulted from exhaustion of this system.
As observed throughout this experiment, the onset of reserpine sedation appeared about

4 hrs

following its administration

with maximal sedation appearing 8-12 hrs later.
sedation was evident by

24 hrs.

Recovery from

In contrast, throughout the

latter half of the chronic recovery experiment several animals
were abnormally excitable
reserpine.

These animals were extremely excitable and very

sensitive to handling.
themselves.

24 hrs following a previous dose of

They also frequently fought amongst
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The development of acute sedation correlated well with
decreased NE levels, whereas brain 5-HT depletion reached a
maximum four hours following reserpine administration and
was maintained at this level throughout the 12th hr (TABLE I,
Fig. 2).

Twenty- four hours following a single dose of reser-

pine brain 5-HT appears to be returning to normal in contrast
to brain NE.

Since sedation was also minimal at this time,

brain 5-HT appears to be a better candidate as mediator of
reserpine-induced sedation.

Althou gh these results are in

conflict with the work of Brodie et al (1 960) concerning equivalent depletion of both amines by reserpine, they do support
his theory that reserpine mediates its effects through 5-HT
depletion rather than NE depletion.
The recovery of brain 5-HT levels following thirty-two
doses of reserpine took on a different character.
levels were 80% above normal
reserpine (TABLE II, Fig. 3).

24

Brain 5-HT

hrs after the last dose of
This increased level correspon-

ded well with the behavioral excitability observed.
Since the appearance of maximal sedation was equally present 8 hrs following the administration of reserpine throughout the chronic experiment, this time was used to compare all
data.

When comparing the effects of reserpine on brain neuro-

humoral levels after one and thirty-two doses of reserpine,
equivalent progressive depletion of both amines was apparent
(TABLES I and II).

However, in subsequent experiments reser-

pine appeared to induce a greater progressive effect on brain
NE than on 5-HT.

The following table has been prepared to

summarize this and subsequent experiments in order to clarify
the preceding statements.
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TABLE IIA
A COMPARISON OF THE EFFECTS OF RESERPINE
ON BRAIN NE AND 5-HT LEVELS OBTAINED
FROM DIFFERENT EXPERIMENTS

fa DEPLETIONa

DAY 1

DAY 32

PROGRESSIVE
DEPLETION
DAY l/DAY 32

5-HT

2t%

31%

16%

NE

37%

73%

51%

a ·- The values presentAd a.re the means of
experiments conducted in subsequent
experiments; TABLES I, II, XI, XII, and
XV. %DEPLETION refers to the percent
of control values at that time.
Therefore, reserpine does appear to have a greater chronic
effect on brain NE levels than on brain 5-HT levels when comparing the progressive depletion of both amines (TABLE IIA).
It should be added that confirmation has since been obtained
in this laboratory which re-emphasizes the results of TABLE IIA.
These observations coupled with the higb brain 5-HT levels observed with chronic recovery experiments (TABLE II), could be
explained on the basis of an increased rate of 5- HT synthesis.
In relation to the hypotheses formulated initially, the
following observations can be ma.de.
1 - As indicated by the serum KS leve ls after one and
thirty·- two doses, reserpine stimulates th e pituitaryadrenocortical axis acutely, but

apparentl~

loses
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its effect during chronic administratio n.

Howeve r,

whether the lack of a chronic effect was due to
pituitary exhaustion it is not clear.
2 - The comparative effect of reserpine on brain NE
levels was greater than on 5-HT levels after single
and thirty-two doses of reserpine.

The differences

in brain levels could be due to an increased rate of
5-HT synthesis during reserpine treatment.

IV.

RESULTS AND DISCUSSION

Effects ££. Reser_Eine in Animals Sub jec t~g to
Daily Forced Restraint Stress
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TABLE III
EFFECTS OF CHRONIC RESTRAINT STRESS ON THE FOOD AND
WATER BALANCE AND MORTALITY RATE OF NORMAL
AND RESERPINIZED MALE ALBINO RATS (32 days)a

n

WATER
INTAKE

URINE
EXCRETION

ml

ml

MEAN
WEIG,HT

G ~IN/DAY

FOOD
INTAKE

g

g

M.R.b

%

CONTROL

8

J.88

18

0

STRESS

8

2.84

18

0

CONTROL +
RESERPINE

8

1.99

STRESS T
RESERPINE

12

0.50

6 .. 6

12.6

50.0

a - All values are means of 32 days/animal/day. Where indicated values are means t S.D. Dose of reserpine was
1 mg/kg, I.P.
b - Abbreviations - M.R. =Mortality Rate (%Dead/Alive)
n =Number of animals studied.
s - Significant from control group.
x - Significant from both the control and stress
z - Significant from all previous groups.
All animals initially weighed about 160 g.

group~.
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TABLE IV
EFFECTS OF CHRONIC RESTRAINT ON THE THYMUS WEIGHTS
OF NORMAL AND RESERPINIZED MALE ALBINO RA TS a

DAY

CONTROL

CONTROL +
RESERPINE

STRESS

STRESS +
RESERPINE

mg

mg

mg

mg

1

399:!"104
{8)

300:1.-44 s
(8)

329±62
(8)

J69X6lx
( 8)

6

34t:!'86
6)

24~~12

313:!14 9
( 8)

231tz7s
(8

18

432::r97
(8)

32t~T7s

366!'81
(10)

167!"64 8 x
(10)

32

385!'63

32~:!64

298:!°69 8

118'!64 8 x
(12)

( 8)

8

8)

( 8)

a - All values are means +
- S.D. Values in parenthesis
represent the number of animals used. Dose of reserpine
was 1 mg/kg, I.P.
s - Significant from control group.
x - S1gnif icant from stress group.
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TABLE V
EFFECTS OF CHRONIC RESTRAINT STRESS ON THE TESTES WEIGHTS
OF NORMAL AND RESERPINIZED MAIE ALBINO RA TS a

DAY

CONTROL

mg

STRESS

mg

CONTROL +
RESERPINE

STRESS +
RESERPINE

mg

mg

l

1.88:!°0 . 28

i.94!0.92

+
1.79-0.30

1.77:!'0.33

6

2.42to.67

2014::to.52

2.16:to.92

2.11to.40

18

2.96!0.50

2.90!'0.64

2.74!0.45

2 .53:to.38

32

2.80:!:'0.45

3.11!0.54

2.05:!0.67

2.20:!0.87

a - All values are means ± S .D.
(None of the values
presented here were significant from any o ther
group). The number of animals studied app e ar in
TABLE IV. Dose of reserpine was 1 mg/kg, I.P.
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TABLE VI

EFFECTS OF CHRONIC RESTRAINT ON THE WET ADRENAL "WEIGHTS
OF NORMA L AND RESERPINIZED MA LE ALBINO RATSa

DAY

CONTROL

mg

STRESS

mg

CONTROL +
RESERPINE

mg

STRESS +
RESERPINE

mg

1

27 . 3:t4. 6

23 . 2:i-1 . 6 8

27 . 5:r1 . 9

25.8:!2.6x

6

3.5 . 8±6 . 0

34 . 2:t3.5

33 ._5:!'6 .o

35 .1:1'3. 3

18

Jl. 0!7. 6

39 . 7--r-5. os

38 . 7! 5.6

39 . 0!4.3 9

32

37 . 8:!'4 .5

49. 1!7 . 68

42 . 7:!·4 . 7

4s .2rs.5s

a - All values are means t s .D . The number of animals used
in this experiment appear in TABLE IV . Dose of reserp i ne
was l mg/kg, I.P.

s - Significant from control group.

x - Significant from stress group
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TAELE VII
EFFECTS OF CHRONIC RESTRAINT S'l'RESS ON THE
DRY ADRENAL WEIGHTS OF NORMAL AND
RESERPINIZED MALE ALBINO RATSa

DAY

CONTROL

STRESS

CONTROL +
RESERPINE

mg

mg

mg

mg

STRESS +
RESERPINE

1

+
6.2-0.2

5 6+-0.2 s

6.8±0.8

.5.8±0.5sx

6

7.1±1.6

8._s±o . 4s

7.7±1.6

8.9±1.3 5

18

8.2:t'1.5

10. 5±1 .5 8

9.8±1.8

ll.?±2.7 8

32

9.1 .. 0.4

...

+
l0.0-2.5

+
12.3-2.9

12.s±1.1 8 x

0

a - All values are means + S.D. The number of Jl.nimals
studied in th1s experiment appear in TABLE IV• Dose
of reserpine was 1 mg/kg, I.P.
8

-

Significant from control group.

x - Significant from stress group.
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TABLE VIII
EFFECTS OF CHRONIC RESTRAINT ON THE %
ADRENAL DRY WEIGHTS (ADW) OF NORMAL
AND RESERPINIZED MALE ALBINO RATSa

DAY

CONTROL

%

STRESS

%

CONTROL +
RESERPINE

%

STRESS +
RESERPINE

%

1

23.o:t4.1

24 .3:r2. 7

24.e±1.5

+
22.3-2.4

6

21.7±4.2

24.o:r1.5

25.3:t1.3

26.~2.6

18

24.st4.1

26.4t1.6

25.6:t .6

29.2±2.5

32

+
24.7-2.7

21.7!8.7

27.4!4.2

+
27.0-4.l

a - All values are means .± S.D. (None of the values presented here were significant from any othe r group).
The number of animals studied appear in TABLE IV.
Dose of reserpine was 1 mg/kg , I. P •
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TABLE IX
EFFECTS OF CHRONIC RESTRAINT STRESS ON THE PITUITARY WEIGHTS
OF NORMAL AND RESERPINIZED MALE ALBINO RATSa

STRESS

CONTROL +
RESERPINE

STRESS +
RESERPINE

mg

mg

mg

mg

1

1.09

0.89

0.90

1 .10

6

1.67

l.0.5

1.30

1.28

18

1.71

1.65

1.57

1.25

32

1.76

1.89

1 • .56

1.54

DAY

CONTROL

a - The dry pituitaries from each group were pooled

(6-8 p ituitar ie s) for accurate weighing and are
expressed as mg/animal ( mean value ).
Dose of r•eserp1ne was 1 mg/kg, I.P.
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TABLE X
EFFECTS OF CHRONIC RESTRAINT STRESS ON THE SERUM
CORTICOSTERONE LEVELS (KS) OF NORMAL AND
RESERPINIZED MALE ALBINO RATsa

STRESS

CONTROL +
RESERPINE

STRESS +
RESERPINE

ug/100 ml

ug/100 ml

ug/100 ml

ug/100 ml

1

24.7±16.0

71.0±28.1 8

51.5±16.2 8

77.9:±'29.osx

6

43.0±24.6

DAY

CONTROL

8).+ • 7±1_5 . 7 SX
(8)

50.3:t30.6
32

33.5±16.9

42.4±28.8

58.7±27.4 9

a - All values are means ! S.D. The number of animals
studied in this experiment appear in TABLE IV. Dose
of reserpine was l mg/kg, I.P.
s - Significant from the control group.
x - Si gnificant from the stress group.
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TABLE XI
EFFECTS OF CHRONIC RESTRAINT STRESS ON
BRAIN SEROTONIN (.5-HT) LEVELS OF NORMAL
AND RESERPINIZED MALE ALBINO RATSa

CONTROL +
RESERPINE

STRESS +
RESERPINE

CONTROL

STRESS

ug/100 ml

ug/100 ml

ug/100 ml

ug/100 ml

796±43
(4)

961±210
(4)

48.5:tl25

8.50±137

698±43

1426:t82J

Cld

567::tlll
(4)

960:t443
(4)

12

67tlf14

67(1:63
3)

522:tl87
(3)

62l~~4

18

7(?:tl48

4)

52.5x160
( 5)

482±45

60.51:41

32

6(55123

55t .....123

482:!:'167
( 6)

605:!/J9

DAY

1

6

(3)

5)

(4)

(4)

a - All values are means ~ S,D.

(4)

(6)

(6)

The number of brain pools
studied is represented in the parenthesis (2 brains/
pool). Dose of reserpine was 1 mg/kg, I.P.

s - Significant from control group.
y -

Significant from control + reserpine g1•oupu
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TABLE XII
EFFECTS OF CHRONIC RESTRAINT STRESS ON THE BRAIN
NOREPINEPHRINE (NE) LEVELS OF NORMAL AND
RESERPINIZED MALE ALBINO RATS 8

-CONTROL +
RESERPINE

STRESS +
RESERPINE

CONTROL

STRESS

uug/g

uug/g

uug/g

uug/g

l

242!68

196!61

182!123

177!82

6

340!218

137!86

182°!91

199!°.52

12

-------

_ _ .... \m _ _ _

161±16

231:!"37

18

590±188

497:!'190

11st12 8

122:t64 8

24

507±74

560:t38

48•88

102.. 305

32

399!96

318:!'23

128:!'61 9

112!73

DAY

s.n.

+
a - Al l values are means _
studied appear in TABLE XI.
1 mg/kg,

r.P.

8

-

'I'ne number or bra in pools
Dose of reserpine was

Sign1f1oant from control group.
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DISCUSSION

--

The Effects -of Chro nic Restraint (RS) -on -~
th e Pituitary-Adrenal

~-

Axis and Various Organ Weights of Normal Male Albino Rats
According to Selye 1 s theories regarding chronic stress,
animals respond differently to individual stresso1 s only in a
1

quantitative way; the responses all being qualitatively the
same.

Therefore, one of the first objectives of this experi-

ment was to characterize the effects of chronic restrain t
stress in normal animals in terms of the G.A.S.
It was found difficult to completely characterize the alarm
reaction, since experiments were designed at six day intervals
(the alarm reaction usually occurs within the first three
of chrinic stress).

d~ys

The alarm reacti on was evident to some

degree by the significant decrease of the thymus weight of
stressed animals on day one (TABLE IV).

There was also a noted

decrease in the pituitary weight which was als o observed by
Turner and Tinerty (195 6) (TABLE IX).

It is difficult to ana-

lyze glandular activity from only a weight change, but on the
basis of the severity of restraint stress , the loss of weight
could be due to ACTH and associated chemical depletion during
extreme activation.
The significant decrease in wet and dry adrenal weights
of normally stressed rats after the first day of the experiment
(TA BLES VJ VII) was ex tremely interesting and unexpected.

In

contrast to this effect, Selye (1950) has observed an increase
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of adrenal weight during the alarm reaction indicating adrenal
byperf'unction.

This effect could also be interpreted as indi-

cating adrenal exhaustion caused by this stress.

This fact,

however, seems highly unlikely.
Another unexpected finding was the initial lack of effect
of RS on the testes weight, which

acco~di ng

should decrease following an acute stress.

to Selye (1950),
The present finding

was confirmed by Albert (1942) who observed a delay in decrease
of gonadal weights following chronic formalin stress (0.2 ml,
I.M.).

This was also observed in this experiment (TABLE V).

The ability of normal male albino rats to adapt to chronic
restraint stress is evident after studying the effects of this
stress on the thymus, testes, adrenal and pituitary weights
(Fi gs .

4 & 5).

Following the initial alarm reaction the con-

vergence of all changes towards original or normal levels is
an excellent example of animal adaptation to external environmental changes.
The inverse relationship which exists between the pituitary
dry weight and %ADW of stressed rats appears to be one of the
clues which may aid in explaining pituitary-adrenal adaptation
(TABLES

VIII~IX:

Fig.

5).

This relationship appears to confirm

the earlier observation that a decrease in pituitary weight
could be interpreted as indicating a state of hyperfunct ion.
Thus, as an animal adapt s to a stressor, the pituitary becomes
less active as indicated by the progressive increase of dry
pituitary ( Fig. 3).

The progressive decrease in the %ADW also

indicates a similar decrease in adrenal function.
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Although an apparent decrease in pituitary and adrenal
function prevails during adaptation to stress, the serum corti1

costerone (KS) levels exhibit no relative adaptation and appear
to be maintained at hi gh levels throu g hout the experiment {TABLE

X, Fig . 6).

If tbe adr enal weights are an indication of corti-

costeroid synthesis and rel e ase, then the concurrent maintenance
of both serum KS and ADW would indicate an increased adrenal
efficiency during adaptation to stress (TABLES VIII and X).

-Th~
~

~ffects

- --

of Chronic Restraint (RS) on the Pituitary- Adrenal

and Var iou s Organ Weights of Reserpinized

~Albino ~

The mortality rat e of reserpinize d rats subjected to RS
was extremely high (50%, TABLE III), and clearly indicates the
inability of reserpinized animals to adapt to chronic forced
restraint stress.

The reserpinized animals subjected to stress

appear to die from starvation effects which seemed to stem from
their inability to adapt to the stress since normal reserpinized
animals demonstrated a mortality rate one - fifth that of the
stressed animals.

The decreased water and food balance caused

by reserpine, attests to this nonadaptation.
The most striking e ffect of r es erpine on the first day
was its apparent inhibition of the effe c ts of RS on the organ
we i ghts (thymus, p ituitary and ad renal) of normal a n imals
(TABLES IV, VI-IX, Fi gs .
changes by approxima t e ly

4 an d 5).
50%. The

It i n hibit e d th e wei ght
effe c ts of r ese rpine on the

testes of stre s se d animals is also int e resting sinc e it appeared
to act indepe nd e ntly of the stre ss by producing a decrease in
weight

(TA BLE V).
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Although reserpine apparently inhibits stress on the first
day, thereafter, nonadaptation pr e vails.

4

and

5,

As observed in Figs .

or gan weight changes are dive r gent in contrast to un-

treated animals under stre s s.

There were s ome si gns of adapta-

tion as indicated by the increased pituitary wei ght and decreased
%ADW on the thirty-second day (Fig.

5).

The serum corticosterone levels indicate tr.at reserpine
does not prevent animals from achieving adrenal adaptation since
these l e vels are equivalent to those of untreated stressed animals (TABLE X, Fig . 6).
That this may not be the case is indicated by

the apparen t

nonadaptation of the pituitary-adrenocortical axis (TABLES VI-IX ) .
In all cases, the progressive increase of adrenal wet weights and
ADW's, would indicate increased adrenal function.

The apparent

decrease in dry pituitary weight (TABLE IX), would also tend to
confirm continued stimulation.

Since no other experimental evi-

dence has been presented, these diver gent results cannot be explained at present.

However, the great difference between the

growth rates of stressed and reserpinized stressed animals, ruay
offer some future explanation.

The fact that starvation may

inhibit the usual detoxication of corticosterone in the liver
of rats (Herbst et al, 1960), may also aid in explaining this
discrepancy.
Re serpine appeared to produce a significant effect of its
own on the pituitary- adrenal axis.

At times, especially at

the onset of the experiment, the effects of reserpine on organ
weights of normal animals were almost mirror images of the effects
of RS in no rmal ani mals (TABLES IV, V, IX, & X).

Another inter-
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eating effect appears on the pituitary gland itself (Fig. 5).
The initial decrease of pituitary weight which occurred on
day one could be caused by nonspecific effects, and thus, may
reflect

a release of secretory substances.

However, on the

eighteenth day this effect could also be interpreted as complete
pituitary exhaustion, as predicted by Kitay et al (1959) and
Maickel et al (1961).

It is interesting to note that reserpine

produces an equivalent effect on the pituitary on day one as
does RS in normal animals.

On the other hand, reserpine plus

stress produces an inhibition of the decreased pituitary weight
as caused by stress alone.

It thus appears that these effects

on the pituitary may indicate different mechanisms which are
antagonistic.

Similar differences were also observed on the

thymus and adrenal weights.
In a final analysis, reserpine appears to prevent adaptation to RS as evidenced by its divergent effects on various
organ weight changes.
The Effects of Chronic Restraint (RS) Stress
and Brain Serotonin

(5 ~HT )

and Norepinephrine

~

the Behavior

(fil~_)

Levels of

Normal and Reserpinized Animals
Normal animals subjected to RS demonstrated an extreme
degree of excitability during the first six days of the experiment.

This behavioral effect decreased progressively with the

duration of the experiment indicating behavioral adaptation.
On the othe r hand, restrained reserpinized animcls were less
excitable at the

o~s et

of the experiment but became progressively

more excitable and difficult to handle as the experiment proceeded.

During the latter half of the experiment reserpinized
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animals appeared vicious as indicated by their attacks upon
the investigator.

To be more specific, reserpinized animals

were quite easily tied down throughout the experiment, but
became increasingly vicious upon release from restraint.
Generally, most of the stressed reserpinized animals displayed some degree of ptosis while under restraint throughout
most of the experiment .

After the sixth day of the experiment,

the feeble state of the animals (animals weighed about

l~O

g)

pre vented an accurate analysis of the degree of ptosis and sedation.

On about the twelfth day the reserpinized animals also

ceveloped

watery secretions around the eyes which made it even

more difficult to determine the degree of ptosis.

Very infre-

quently normally stressed animals developed similar secretions.
To summarize, reserpinized animals became progressively
excitable upon release from restraint, although the

stres~

was

initiated with greater ease than with the control animals.

Thus,

there were no indications that reserpinized animals evidenced
any sort of behavioral adaptation to chronic RS.
There also appeared to be neurohumoral adaptation occurring
concurrently with behavioral adaptation.

The problem in anal-

yzing these results is the fact that the 5-HT and NE brain levels
of normally stressed animals were not significantly different
from control data (TABLES XI-XII).

As seen in Fig. 6, there is

an increase in brain 5-HT levels and a decrease in brain NE
levels which correspond very well with the general activity of
the stressed animals during the first six days of the experiment.
As was pointed out above, these animals were extremely excited
during the first six days of the experiment.
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Although there !s little statistical significance to defend

the findings presented, the importance of a possible cor=

rela tion between behavioral adaptation, a nd brain 5-HT and NE
levels must not be denied.
One of' the rro st importan t observations made in this experiment was the fact that chronic stress (RS) will inhibit the
usual S=HT releasing effects produced by chronic reserpine administration (TABLE XI, Fig .

7).

The effects of RS on brain

NE were lacking as was previously demonstrated acutely by Brodie
et al (1960).

The signifi cance of these findings will be dis-

cussed later.

To determine whethel' chronic str ess inhibited re-

serpine sedation a. s we 11 as bra.in .5=HT was very diff' icu l t.

In

relation to the correla. tion betwe en behavior·al and neurohumoral
adapts. t :ton in re serpinized a.nirnals subjected to chronic stress,

the fact that stress had no effect on brain NE levels appears to
associate this amine with the progressive increased behavioral
activity associated with this group of animals.
One point, however, was very obvious.
induce a progressive depletion of brain

NE (Fig.

4).

Reserpine did not

5~HT

but it did to brain

On the other hand, Brodie and Shore (1957) have

postulated that reserpine should produce a prog1•ess i ·ve depletion
of both brain amines since they do so acutelyo

The above

obser~

vations were also present in the first experiment (TABLES I and

II)o
.§£,m,ma.r'Y

In view of the hypotheses pre sented earlier-, this

experi~

ment has certainly produced effects which were not expected.
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Therefore, the initial hypothesis will now be discussed in relation to this experiment.
Hypothesis I - Reserpine has not been found to inhibit
chronic restraint stress to any degree.

In fact reserpine

appears to be an acute stinru.lator of the pituitary- adrenocortical axis and appears to prevent animals from adapting to this
stress.

How reserpine prevents adaptation cannot be determined

at present.
Hypothesis II - Reserpine do es appear to ceplete brain 5-HT
equally throughout this experiment.

The fact that brain NE was

depleted progressively throughout this experiment in contrast
to brain 5 - HT, make s it impossible to conclude as to which neurohormone is responsible f'or reserpine-induced-sedation.

The fact

that it was not possible to positively state whether chronic
stress inhibits reserpine sedation as it inhibited 5-HT release ,
gives added support to the preceeding statement.
Hypothesis III - Since there are no clear cut results which
would e ither prove or disprove the stated hypotheses, there does
appear to be secondary mechanisms which may be responsible for
the observed effects.
The data obtained by chronically stressing reserpinized
rats has made it necessary to fornru.late two ancillary hypotheses.
Hypothesis IA - If reserpine is specifically stimulating
the pi tu 1 tary- adrenal axis, then s ingle and cbr-oni c graded doses
of reserp ine s hould produce graded effouts on this system .
Hypothesis TIA - Since reserpine did not induce a progressive
depletion of 5- HT, but only of NE, and maintained an equivalent
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degree of sedation th roughout the experiment, it is postulated
that r eserp ine is inducing a rap id synthesis o i' 5-H T.
To t es t these hypotheses, a chr onic grad ed dose exper iment
i nvolv ing reserpine was also conduct ed .

The above hypotheses

will be di scussed i n vi e w of these three major exper ime nts.

IV.

RESULTS AND DISCUSSION

Effects .2.f §ingle !!!£ ReE,eated Graded Doses
~serp1. n~.

1£

Normal Ma.le

Albino
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TABLE XIII
EFFECTS OF SINGLE GRADED DOSES OF RESERPINE ON
PITUITARY-ADRENAL FUNCTION IN NORMAL ALBINO RATS

ADRENALz
DRY
WEIGHT
(ADW)

DOSE

SERUM
CORTICOSTERONE
(KS)

WET
PITUITARY
WEIGHT

ug/100 ml

mg

16.0±4.0

-------

oY

2i.6:t14.o

4.6:!:0.7

0.5

lJ.8!11.6

4.2!0.9

1.0

27.0:!:'12.oa

3.8!0.6

2.5

34.0!7.9a

4.4:to.8

38.3~12.oa

5.3!0.5

mg/kg

mg/lOOg

(6)

(8)

(8)

(?)

5.0
(8)

~i-

-

~Hf.

-

4.0!0.3

Numbers in parenthesis represent the number of animals
studied.
All values are means +
- S.D.

a - Significant from the control group (0).
y - These animals were administered 2 ml/kg of a 25% solution

of the reserpine v ehicle.
z - The organ weights presented are mg/100 g of animal weight.
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TABLE XIV
EFFECTS OF REPEATED GRADED DJSES OF RESERPINE (32 days)
ON PITUITARY-ADRENAL FUNCTION IN NORMAL MALE
ALBINO RATS
ADRENAL
DRY
WEIGHT
(ADW)

rosE

SERUM

CORTICOSTERONE
(KS)

DRY
PITUITARY
WEIGHT

ug/100 ml

mg

25.0!12.o

9.8!o.8

oY

27.3:!0.o

7.1:!2.4

o.5
( 16)

25.8:t10.6

8.3!1.1

9.97!2.6

27.9±'105

8.6'!2.2

l0.0.5±2.8

27.4±13.6

7.9:t1.4

10.0

18

-------

mg

mg/kg

( 6)

1.0
(10)

2.oIII

(18)
2.0
(6)
~H~

-

All values are means -+ S .D.

z - Values in parenthesis represent the number of animals
studied.

y - All animals in this experiment were given food ad libitum
except for this group; they received 18 g/animal. The
final weights of animals in this exp er iment were as
follows: ( 0 ) 339 g, (OY) 271, ( 0 .5) 240 g, (1) 220 g,
and (2.0) 204 g.
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TABLE XV
EFFECTS OF SINGLE AND REPEATED GRADED DOSES OF RESERPINE
ON BRAIN SEROTONIN AND NOREPINEPHRINE LEVELS
OF NORMAL MALE ALBINO RA TS
REPEATED I OSES
(32 Days)

SING LE DO SES
DOSE

5-HT

NE

DOSE

NE

uug/g

uug/g

0
(7 )

605~77

498~191

o.5

426'!27

76:t5aa

mg/kg

uug/g

uug/g

mg/kg

.0
( 4 )-!!-

577:51.iH!-

245~77

0.5

516:!:99

129±84.

f 4)

5-HT

( 5)

( 2)

1.0

458:!'28

123!]9

1.0
(10)

427t87
563±69

72:t51
645±168
(3)

2.5

4102')6

1912'36

2.0
(4)

461%65

94±57
(2)

5.o

365!56

148!39

2.oIII

6~3;!'79

107!51

(4)

(4)

{4)

*-iHi-

-

i!-*i!- -

(3)

7 9iHH!-

Values in parenthesis represent the number of pooled
assays (2-4 brains/pool).
All values are means

± S.D.

These values a.re significantly different from the values
above at 2 mg/kg. The values below represent a pool of
three assays.

III - Extremely excitable group.
a - The values in parenthesis in this column represent the
number of assays in which NE could not be determined.
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Fig. 8, ? Effects of single and chronic grade d doses of reserpine on brain serotonin (5-HT) levels of normal male albino
rats.
Single doses ( ..._. ) and chronic doses ( A- --A) are
given. Each point repr~sents the mean of 3-7 brain pools
(2-4 brains/pool). The chronic experiment was conducted for
32 days.

DISCUSSION
~1ng~e

graaed aoses of reserp1ne resulted in a dose-re-

sponse effect on the

7).

p1tu1tary~adrenal

axis (TABLE XIII, Fig.

The sigmoid character of serum KS levels does indicate

a epeo1f1c stimulatory effect by reserpine.

The attempt to

permit animal adaptation to the vehicle and injection by two
weeks of preinjeot1on re-emphasizes the specific effects of
reserpine on this system.

However, the vehicle was also ad-

m1n1s tered 1n a greater dose (oa, TABLE XIII).

As indicated,

this concentration also had an effect on the pituitary-adrenal
axis, but was not as potent a streseor as reserpine.
The effects of graded doses on adrenal weights are extremely unusual and do not present the same dosewresponee
e!'feo t as observed with reserpine and serum KS (TABLE XII'I).
The character of the pituitary- weights ve, dose of

rese~p1ne

1nd1oates a b1phasio action of reserpine, first st1mula.t1on,
then 1nh1b1t1on of the p1tuttary-adrenal axis (Fig. 7),

The

complementary nature of the :t'elat1onsh1p between the ADW and
pituitary weight re-emphasizes this possible b1phae1c effect
of reserpine on the p1tu1tary... adrer1al axis.
the b1phas1o e:f'f'eot on th1a system,

In oontz•ast to

erum KS 1nd1oatee only

a monophas1o st1mulat1ng effect by reserpine on the pituitary•
adrenooort1oal axte,
e1de~s

These oonolusione

re valid if one con•

an 1norease 1n adrenal weight 1n oontr at to a deor ase

1n pituitary we1gh.t,

~

an 1nd1oa.t1on of p1tu1tary-e.drenooort1 ...

70

71
cal axis hyperfunction.

The %ADW and dry pituitary weight re-

lationships in normally stressed rats would appear to confirm
such a conslusion (Fig. 6).
This effect could be explained if reserpine possessed both
central and peripheral effects.

In support of such a possib111ty,

Verdesca et al (1961) has shown that 5-HT stimulates adrenal
function directly, and increases corticosteroid secretion.
Since reserpine also induces peripheral release of 5-HT (Erspmer,
1961), a sedative dose could be envisaged as producing both an
inhibition of the pituitary-adrenal axis centrally, and a stimulatory effect peripherally on the adrenal cortex directly.

Such

a mechanism could explain the apparent biphasic effects of single graded doses of reserpine.
The reserpine control animals present during the restraint
stress experiment, exhibited unusually high adrenal dry weights
(TABLE VII).

This effect was not duplicated in this experiment.

In several other experiments conducted in this laborato1 y, the
1

adrenal dry weights of animals receiving 1 mg/kg of reserpine (32
days) were 10.0 mg per animal.

This apparent discrepancy may be

due to possible undue stress provided during the restraint stress
experiment.

The high serum KS levels of this experiment, as com-

pared to the first experiment (TABLE X) also indicates that such
increased stress conditions did exist.
After thirty-two days of daily administration of reserpine,
no effective stimulation of the pituitary=adrenal axis was apparent as compared with the effects of single graded doses
(TABLES XII and XIII).

What occurs between the first and thirty-

second day might be explained by three possibilities:
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1.

Reserpine acts as a nonspecific stressor to which
the animal eventually adapts {TABLE X).

2.

Reserpi ne causes inhibition by contirnled deple tion
of pituitary stores of ACTH (K itay e t al, 1959 ).

3.

Res erpine produces a direct stinru.latory effect on
the adrenal gland via peripheral serotonin (5-HT )
depletion, to which the adrenal e i tber adapts or
eventually is its elf exhausted by ch1,onic s t1mulat1on.

Single graded doses of reserpine produced a progressive
depletion of bra in .5-H 1r indicating a causal re la tionsh ip
tween dos€' and eff'e ct (TABLE XV, FigJ 8 ).

be~

No such rela tion-

sh 1.p was established for brain NE wb 1ch is in contra.a le ti on
to Brodie and Shore (1 959 ) who have established equivalent
de pletion of both amines following a s ingle dose of reserpine.
Sinc e reserpine-induced sedation a.ppear•s to cot relate
better with brain 5-HT as was observed in previous experiments,
( TABLE I) it is suggested that reserpine-induced sedation may
ultimately be caused by bra.in 5-HT release .
Chronic administration of graded doses of reserpine indicated somewhat of a rever sal of 5-HT depletion wrile NE levels
were lowe r than the first day.

In fact, in almost half of

the assays conducted on animals und er cbronic admin1.stra. tion
of' reserpine, no NE could be detected ( TABLE XV).
As indicated in the first experiment (TABLE XI), 1 mg/kg
of reserpine did not induce progr essive depletion of 5-HT
with time.

The

0.5 mg/kg dose of reserpine in this experime nt ,

however, did appear to produce progressive depletion of 5-HT
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in contrast to the apparent inhibition of 5- HT depletion produced by 2 mg/kg (TABLE XV, Fig. 8).
The behavioral sequences involved during this experiment
clearly indicate the ability of reseriine to produce some excitatory effects.

It was observed tbat at about half way tbrcugh

the experiment, animals at all dose levels became extremely exc 1table

24

hours following a dose of reserpine. - (This was

al so indicated previously, TABLE I.).

There was also evidence

of extreme excitability in a group of animals receiving 2 mg/kg
of reserpine.

It is interest ing to note that these animals

evidenced high brain 5-HT levels and a low mean KS level of 18
ug/100 ml of serum.

As indicated in TABLE IV, group III, al-

though extremely excitable, they demonstrated KS levels below
normal.

Thus, stress could not be implicated in producing such

high 5-HT levels (Fig.

7).

One of the initial objectives of this experiment was to
attempt to separate rats resistant or sensitive to reserpine
in order to obtain added information as to tbe mechanis ms of
reserpine tranquil1zat1on.

However, due to the lack of suff1-

c ient data, these objectives were not satisfied.
In relation to the ancillary hypotheses presented in the
previous experiment, there are no c lear indications that chronic
reserpine

treatmen~

produces chronic stimulatory effects on the

pituitary-adrenocortical axis.
Tbe previous hypothesis that reserpine is inducing an increase in

br~in

5-HT synthesis has also gained further support.

The reversal of the degree of 5-HT depletion with increasing
doses of reserpine does lend support to a possible feedback mechanism.

V.

GENERAL DISCUSSION

The basic assumption in this work has been that animals subjected to chronic environmental stressors will respond
differently to the actions of drugs and thus, alter their
usual effects.

This investigation has demonstrated the util-

ity of studying the effects of drugs in animals under the
influence of chronic stress, especially those which affect
the central nervous system.
At the onset of this investigation, several hypotheses
were formulated which were then tested by subjecting reserp1n1zed rats to chronic restraint stress.

As has been noted,

by necessity, two ancillary hypotheses were formulated and
tested in order to elucidate the chronic effects of reserpine
on the brain NE and 5-HT and serum KS.

In relation to these

hypotheses, the following discussions will be utilized in
relating the results obtained to the mechanism of action of
reserpine.
Neurochemical adaptation which appears to parallel behavioral adaptation has been characterized in normal and
reserpinized rats.

The increased behavioral activity assoc-

iated with the initiation of restraint stress closely follows
the increased brain 5-HT levels and decreased brain NE levels,
both values returning to normal with behavioral adaptation
(Fig. 6).

Serum cortioosterone levels aside from being an

index of adrenooortical activity, also appear to be an
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excellent index for behavioral adaptation.
The results from previous investigations indicate the
validity of these observations.

Thus Garattini et al (1960)

found that electroshock produced an increase ln brain 5-HT
levels in rats, whereas Maynert and Clingman (1962) demonstra·
ted depletion of brain NE in rats following a cold stress

(4°c).

The significance of these findings can be observed
assuming that depletion of either neurohumoral substance be
int erpreted as a decrease of neurotransmitter release associatAd wit!' increased neuronal activity.

If' this assumption

is oorreot, then during the initial phases of chronic stress,
the activation of an NE dependent excitatory system in con ..
trast to the inhibition of a

5-HT

dependent system, could

account for the behavioral activity observed.
Whether these neu rochemic als are actual neurotransmitters
released from centrally located axons is still controversial.
Grundfest (1957), in summarizing research from previous years,
concludes that central nervous transmission is
via neuroohemioals.

ac~omplished

The evidence presented in favor of this

arose from his inability to demonstrate electrically excitable
central dendrites.

Rothballer (1959) and Brodie and Shore (1957)

also contend that changes in brain NE represent fluotuationt of
excitatory activity initiated by an adrenergic system.

Brodie

further postulates that 5-HT is released from a cholinergic
mechanism during depressive activity.
In relation to these previous investigations, Whittaker
(1961) and DeRobertis (1962) have isolated both NE and 5... HT
from a centrifuged brain fraction which contained nerve endings.
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Although these findings are .· not conclusive proof of the
physiological roles of 5-HT and NE in the CNS, they do give
encouragement to the interpretations presented in this investigation.
So far, these interpretations have been based on release
mechanisms associated with increased neuronal activity.

How-

ever, when one consideres drug effects, different interpretations can arise.

The effects of drugs on neuronal activity

can be looked at in several ways.

First, a drug could stim-

ulate a nerve which would then release a transmitter substancf.
Secondly, a drug could act by releasing the transm1 tter withou t stimulating the nerve directly.
cases would be the same.

The end result in both

The second possibility would assume

that the transmitter is acting as though its source was stimulated.

However, this does not have to be, since many workers

have shown that reserpine inhibits peripheral nervous transmission by exhausting NE from the ANS (Trendelenburg, 1961).
Bonnycastle et al (1962) observed an increase in brain
5-HT levels in rats receiving sedatives such as phenobarbital
and dilantin.

On the other hand, Pletscher et al (1958) obser-

ved a similar increase with Iproniazid, a CNS stimulant.

Thus,

once again these interpretations arrive at neurohumoral crossroads.

Some light may be shed on this problem through a

recent paper by Schanberg and Giarman (1962).

These wo r kers

found that reserpine increased the ratio of "Fr ee/Bound"

5-HT in the brain, whereas Iproniazid dec r ease d this ratio.
They concluded that the increased brain 5-HT levels produced
by Iproniazid was an increase in the bound fraction, thus
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decreasing the total amount of 5-HT accessible to postsynaptic
sites.

Here again, if we assume that the free amount of the

neurohumoral agent 1s associated with inc reased neuronal activity, 5-HT does appear to be causally related to a depressant
mechanism.
Brodie and his co-workers (1961 ) have provided go od evidence that reserpine produces sedation by releasing serontonin
from its normally inactive sites.

They postulate that after

release, 5-HT then induces CNS depression at some post synap t1c
site.

They have also demonstrated that cold stress will pre -

vent reserpine sedation concurrently with an inhibition of
the normal 5-HT depletion.

Since NE remains depleted, they

conclude that reserpine acts via 5-HT and not NE .
Chronic restraint stress was also found to prevent 5-HT
depletion by reserpine.

However, in these experiments reser-

p1nized stressed animals exhibited increased behavioral excitability concurrently with depleted brain NE, while brain 5-HT
levels remained approximately normal (Fi g. 6).

NE is thus

associated again, with increased CNS excitation.
It should be pointed out again that stressed animals
receiving reserpine demonstrate neurotic behavior after re lease fro m restraint, though they appeared to be somewhat
sedated while under restraint.

This observation is extremely

important for it cannot be concluded that this stress definitely inhibited reserpine-induced sedation.

In other words,

althou gh these animals could have been under sedation, their
r eactions to change were violent.
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Reserpine, therefore, appears to be stimulating both an
inhibitory and excitatory brain mechanism since RS causes only
NE depletion which is apparently associated with an excitatory
mechanism.

This postulate is correct if the assumptions made

previously are valid.

Trendelenburg (1961) in a recent review

article concerning the ANS, points out that reserpine produces
its peripheral effects by complete exhaustion of peripheral
NE stores.

Thus, reserpine produces a chemical sympathectomy.

Insofar as brain NE is concerned, it could be detected in
only half of the assays after 32 days of reserpine administration (total NE depletion was about 90%).

Reserpine, there -

fore, may be producing exhausive depletion of the central sites
of NE as well, thus producing a central hypersensitity

s1~1lar

to nerve postsynaptic hypersensitivity following denervation
experiments.

Such an apparent hypersensitity may be respons-

ible for the behavioral excitation observed in reserpinized
rats subjected to chronic restraint stress.
Past investigators have also demonstrated that reserpine
causes a general release of several amines even including
histamine in some species of animal (Burns and Shore, 1961).
Reserpine, therefore appears to be producing a specific effect,
sedation, through a nonspecific mechanism.

Thus, reserpine

should also induce depletion of brain 5-HT to eventual complete
exhaustion if its action is a simple matter of preventi ng various amines from being bound.

Reserpine, however, appears to

induce an increased rate of 5-HT synthesis through a possible
feedback mechanism.

Such a mechanism was also suspected in
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relation to MAO inhibitors by Costa et al (1961).
Reserpine (1 mg/kg) appears to deplete brain 5-HT levels
equally throughout this investigation (Fig. 6).

Since the

degree of sedation was al so unchan ged in no1•mal animals
throughout the 32 days, it would be logical to assume that
the rate of 5-HT synthesis and release were equivalent .
assumption can be made since the

This

% depletion of 5-HT and seda-

tion are causally related to the dose of reserpine (Fi g. 8).
It was observed that

0.5

mg/kg of reserpine produced a

progressive depletion of 5-HT over 32 days (Fi g. 8).

In con-

trast, 2 mg/kg produced an inhibition of 5-HT depletion; some
animals exhibited levels above normal (TABLE XV).

A possible

5-HT feedback mechanism involving the free to bound ratio of
this amine may therefore be indicated.

Thus, the rate of syn-

thesis of 5-HT increased in some proportion to

%depletion.

As indicated at the 2 mg/kg dose of reserpine, the rate of 5-HT
synthesis could be greater than its release.
A second proof of such a mechanism was evident in studying the recovery of brain 5-HT following one and thirty doses
of reserpine (1 mg/kg), (Fig. 3).
levels,

24

The increased brain 5-HT

hours following the last dose of reserpine, could

be explained on the basis of an increased rate of synthesis,
since the 5-HT levels were below normal 8 hours after admin,.
istratior of the dJug. The rate of NE synthesis did not appear
to change in any experiment conducted.

The obvious accumula-

tion of brain 5-HT could be explained on the basis of its inability to cross the blood-brain barrier (Erspamer, 1961).
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The behavioral sequences observed along with these increased brain 5-HT levels were also interesting.

Throughout

the latter half of this experiment, animals at all doses appeared extremely excitable
of reserpine.

24

hours following a

previo~s

dose

The animals appeared to be hypersensitive to

all external stimuli.

These behavioral changes could very

easily be explained if the brain 5-HT is not bound to an intracellular site.

If this increased level of 5-HT represents a

"Free" form, then 1 t could be bloc king its own inhibiting effects in a manner similar to several cholinerg1c mechanisms
(Brodie and Shore, 1957).
The interpretations of these results indicate that reserpine may be producing its sedative chronic effects by inducing
a continuous release of brain 5-HT ("Free"), which is main
ta1ned by an increased rate of synthesis.
The fact that progressive brain NE depletion was not paralleled by an increased degree of sedation supports the contention that reserpine is producing its effects via an increase in
"Free" brain 5-HT levels.
The ability of reserpine to prevent adaptation was demonstrated beyond any reasonable doubt.

The means by which it

accomplished this, however, is a very debatable subject.

From

all of the demonstrated effects of reserpine, adaptation to
chronic RS is prevented by apparent starvation effects,

It

was observed (Tables IV-IX) that none of the organ weight
changes associated with adaptation in normal animals were
observable when an animal receiving reserpine was also subjected to RS.

The pituitary-adrenal axis, however, appears
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to be somewhat operable einoe high KS levels are maintained
even to the 32nd day, {TABLE X), (Fig. 6) ..
One interesting observation was made by Rosenkrantz and
Laferte (1960, and Verdesoa et al (1961).

These investigators

have demonstrated that serotonin stimulates the adrenal cortex
directly, inducing e. release 01' corticosteroids .

Since reser•

pine also depletes peripheral 5·HT in the rat (Erspamer, 1961),
1 t is ·-very tempting to apeou la. te that the 1 noreased dry we 1gh ts

of :r:•eserpinized animals (Fi g.
of

5~HT

on the adrenal.

4) were due to a dire ct action

This fact might also explain the

con~

flioti.ng results of single graded doses of rese!•pine on adrenal
dry weights (Fig. 7) and pituitary weights.
Although all of this information has been accumulated and
scrutinized, we still cannot answer why a reserpinized animal
does

not adapt to this stressor.

Of the three biochem1oal me""

che.n1sms assayed, (brain 5•HT and NE; serum KS), the only one
which appears to be exhausted or below normal 1n reserp1n1zed
animals subjected to RS, 1s brain NE (Fig. 6).
would associate

non~adaptat1on

Since one

with the lack of some

phys1olo~

gioal mechanism, it would be interesting to speculate a relaw
t1onsh1p 'between the apparent exhaustion of NE with non ... adapta ...

tion.

This reflection becomes even more interesting when one

compares Cannon's WJrk (19 32) with true sympathectomy, with
Trendelenburg•s remarks (1961) concerning e. drug sympatheotomy
e.s pro du oe d by reserp1 ne.

Necina and Krejci (1961), added to this relationship by
demonstrating that the usual peptic ulcers produced by

reser~

p1n1zed animals subjected to cold stress (6 hours), could be
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completely inhibited by administering d1hydroxyphenylalan1ne
{DOPA), a precursor of NE.
5~

They also observed that the usual

mortality in reserpinized animals subjected to cold stress

could also be prevented by DOPA.
In relation to this 1nvest1gat1on, on the 32nd day, brain
NE was barely detectable.

This, of course, 1s no ind1oat1on

of what occurs peripherally.

However, after 32 doses of re-

serpine, the usual spinal reflexes associated with sacrifice
were completely absent.

This very dramatio effect may indi-

cate the loss of all ANS reflex ability.
In view of this data concerning NE and adaptation to stress,

.

it is suggested that
NE may play an important role at the t1ssue
'
level, in enabling animals to adapt to all stresses.
Initially 1t was mentioned that drugs potentially possess
the ability to affect several segments of the pituitary
cortical axis (Fig. 1).

adreno~

Chronic restraint stress by its very

nature stimulates the peripheral side, activating the complete
chain of command ill1c1t1ng oortioosterone release into the
' general circulation at the opposite side.

Reserpine on the

other hand, acutely tnduoed oortioosterone release.

Where re-

serpine acts, however, is not so clear.
The ~ depletion of brain 5-HT appears to be somewhat
causally

related to increased serum KS levels.

Westermann

et al (1962) postulated that reserpine induces serum KS re•
lease by increasing the "Free" brain 5-HT levels in the Limbic
System of the brain, whioh in turn induces ACTH release,
bly via the CRF of the hypothalamus.

poss1~

If their proposal is

correct, then reserpine should either induce a similar increase
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in serum KS levels after 32 doses as after a single dose, or
should pt•oduce inhibition of the p1tu1tary-adrenooort1cal axis
by exhaustion.

In contrast, neither of the above possibilities were clearly
present in this investigation.

Serum KS levels were neither in-

creased nor decreased following chronic administration of reserpine.

Since chronic bratn S-HT depletion was not causually re-

lated to increased serum KS levels, the hypothesis that ACTH is
dependent on "Free" brain 5-HT levels, was not supported in this
1nvest1gat1on.
That the divergent effects produced by reserpine on p1tu1tary-adre nooort 1cal .f'unction (serum KS levels vs. pltuitaryadrenal weights ) could be due to a possible direct effect of
peripheral
tive.

5~HT

on the adrenal cortex, is certainly 1mmagina-

If such an effect were proved, much of the oontrad1ctory

results obtained with reserpine could be reot1f1ed.
Thus, where reserpine acts in producing 1ts effects on the
pitu1tary-adrenooort1cal axis, still remains a mystery.
Concerning these two hyp®theses, the following final statements are
IA.

presented~

Reserpine does not appear to produce chronic

st1mulat1on as indi-

p1tu1tary~adre nocort1cal

cated by serum KS levels.
data

d~es

However, indirect

1nd1oate that reserpine may possess

a bibasic effect on this system which could be
eclipsing the true picture.
IIA.

Reserp1ne - 1nduoed brain

5~HT

release appears to

correlate better with sedation than does NE.
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Proof that reserpine is inducing 5-HT synthesis has been presented.

Whether such a

mechanism can explain the mechanism of
action of reserpine awaits more persuasive
evidence correjat1ng reserpine sedation and
brain 5-HT levels.
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VI.

SUMMARY AND CONCLUSIONS

The study of the influence of chronic stress in animals
receiving a drug, especially one which modifies CNS activity,
was proven to be a very worth while venture.

Aside from add-

ing to the information concerning the action of a drug, the
influence of the drug on chronic stress can also aid in the
elucidation of basic endocrine mechanisms concerning the stress.
In view of the experiments conducted in this investigation and
their interpretations, the conclusions of these efforts are
now presented.
1.

Animals subjected to a chronic forced restraint stress
adapted well in terms of Selyers General Adaptive
Syndrome.

P1tuitary-adrenocort1cal adaptation may

involve an increase in the efficiency of tbis system.
2.

Behavioral adaptation associated with restraint
stress was observed to be related to brain neurohumoral levels.

Thus, hyperexcitab111ty was assoc-

iated with increased brain 5-HT levels and decreased
brain NE levels.

3. Reserpine (1 mg/kg) prevented animals from adapting
to the chronic stressor of forced restraint.

4.

It was postulated that reserpine presented adaptation by producing a chemical sympathectomy.

These

results suggest the possible significance of the sympathetic division of the ANS and adrenal catechol
amines in enabling animals to adapt to chronic stress.
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5.

Reserpinized animals reversed the behavioral adaptation demonstrated by normal animals.

The progressive

increase in behavioral hypersensitivity observed was
associated with the progressive depletion of bra1n
NE levels whereas brain 5-HT levels remained normal
throughout this period of activity.
6.

Evidence was presented that reserpine induced an increased rate of 5-HT synthesis with no similar effect
on brain NE.

The supranormal levels of brain 5-HT

at higher chronic doses of reserpine and observed in
brain 5-HT recovery studies, indicates the existence
of a possible serot1nin feedback mechanism involving
the bound and free concentrations of this amine.
These high serotonin levels were also associated with
behavioral hyperactivity.
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